Cancer - Cancer PHGKB -

Specific PHGKB|Cancer|PHGKB

What's New

Last Posted: May 31, 2019

---

• Genetic Testing After a Terminal Diagnosis—Providing Purpose  
  J Solimine, JAMA Oncology, May 30, 2019
• Grail, a deep-pocketed startup, shows ‘impressive,’ if early, results for cancer blood test  
  M Herper, Stat News, May 31, 2019
• New Drugs, New Side Effects: Complications of Cancer Immunotherapy  
  NCI, May 2019
• Next Generation Sequencing—Testing Multiple Genetic Markers at Once  
  MD Ewalt et al, JAMA Oncology, May 30, 2019
• Tumor Mutation Burden—From Hopes to Doubts  
  A Addeo et al, JAMA Oncology, May 30, 2019
• Genetic Variation in LPA, Calcific Aortic Valve Stenosis in Patients Undergoing Cardiac Surgery, and Familial Risk of Aortic Valve Microcalcification.  
  Perrot Nicolas et al. JAMA cardiology 2019 May
• Assessment of tumor mutation burden calculation from gene panel sequencing data. 
  Xu Zhenwu et al. OncoTargets and therapy 2019 123401-3409
• Avoiding over- and undertreatment in patients with resected node-positive breast cancer with the use of gene expression signatures: are we there yet?  
  Matikas A et al. Annals of oncology : official journal of the European Society for Medical Oncology 2019 Apr
• Clinical utility of custom-designed NGS panel testing in pediatric tumors.  
  Surrey Lea F et al. Genome medicine 2019 May 11(1) 32
• Cost-effectiveness analysis of multigene expression profiling assays to guide adjuvant therapy decisions in women with invasive early-stage breast cancer.  
  Hannouf Malek B et al. The pharmacogenomics journal 2019 May
• Evaluating gene fusions in solid tumors - Clinical experience using an RNA based 53 gene next-generation sequencing panel.  
  Selvam Pavalan et al. Cancer genetics 2019 Apr 233-23432-42
• Evaluation of Cancer-Based Criteria for Use in Mainstream BRCA1 and BRCA2 Genetic Testing in Patients With Breast Cancer.  
  Kemp Zoe et al. JAMA network open 2019 May 2(5) e194428
• Gene Expression Profiling for Diagnosis of Triple-Negative Breast Cancer: A Multicenter, Retrospective Cohort Study.  
  Wang Qifeng et al. Frontiers in oncology 2019 9354
• Genetic polymorphisms of vascular endothelial growth factor (VEGF) associated with gastric cancer recurrence after curative resection with adjuvant chemotherapy. 
  Kim Yeon-Ji et al. BMC cancer 2019 May 19(1) 483
• Identification of Hub Genes Associated With Progression and Prognosis in Patients With Bladder Cancer.  
  Yan Xin et al. Frontiers in genetics 2019 10408